GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated June 3, 2024, serves as a notification to the market regarding the company's total voting rights and capital structure. The data reflects the status as of May 31, 2024, in conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R.
Key Financial Metrics
The filing does not provide financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a capital structure notification.
Material Changes
The filing does not disclose material changes in financial performance compared to prior periods. It solely reports the current share capital composition.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, risk factors, contingencies, or unusual items. Its purpose is to provide the denominator for shareholder interest calculations under UK disclosure rules.
Key Facts for Investors
- Issued Share Capital: As of May 31, 2024, GSK Plc had 4,314,134,937 Ordinary Shares of 31 1/4 pence each.
- Treasury Shares: 169,171,155 Ordinary Shares were held in Treasury.
- Total Voting Rights: The total number of voting rights is 4,144,963,782.
- Usage: This voting rights figure is the required denominator for shareholders calculating notification thresholds under FCA rules.